M. E. Scheulen

A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV

D. Strumberg, M. Scheulen, L. Edler, 2007, British Journal of Cancer.

Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer

F. Lordick, D. Strumberg, R. Hilger, 2012, Investigational New Drugs.

Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer.

D. Strumberg, S. Seeber, M. Scheulen, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.